Stay updated on Belantamab Mafodotin vs Pom/Dex in RRMM Clinical Trial
Sign up to get notified when there's something new on the Belantamab Mafodotin vs Pom/Dex in RRMM Clinical Trial page.

Latest updates to the Belantamab Mafodotin vs Pom/Dex in RRMM Clinical Trial page
- Check4 days agoChange DetectedThe page's Related topics section had entries for 'Multiple myeloma' and 'MedlinePlus Genetics' removed. This alters the navigational links but not the study data.SummaryDifference0.1%

- Check11 days agoChange DetectedThis update adds glossary-style “Multiple myeloma” related topic links (including MedlinePlus Genetics) and advances the page’s software/document revision from v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check18 days agoChange DetectedAdded Revision: v3.5.2; Deleted Revision: v3.5.0.SummaryDifference0.0%

- Check25 days agoNo Change Detected
- Check33 days agoChange DetectedDate entries were added (2026-03-31, 2020-04-02, 2026-03-13, 2026-03) and several related-topic items, including 'Multiple myeloma' and 'MedlinePlus Genetics', were removed.SummaryDifference0.2%

- Check47 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0 on the page. This reflects a new page version being published.SummaryDifference0.0%

- Check54 days agoChange DetectedAdded related topics: Multiple myeloma and MedlinePlus Genetics to the page. This provides contextual information about the disease and access to genetics resources for readers.SummaryDifference0.1%

Stay in the know with updates to Belantamab Mafodotin vs Pom/Dex in RRMM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Belantamab Mafodotin vs Pom/Dex in RRMM Clinical Trial page.